147 results on '"Xu, Lu-Hong"'
Search Results
2. Prognostic value and outcome for acute lymphocytic leukemia in children with MLL rearrangement: a case-control study
3. Extracellular HMGB1 interacts with RAGE and promotes chemoresistance in acute leukemia cells
4. DNA index as prognostic factor in childhood acute lymphoblastic leukemia in the COG-TARGET database
5. Myeloid sarcoma is associated with poor clinical outcome in pediatric patients with acute myeloid leukemia
6. NLRP1 promotes TGF-β1-induced myofibroblast differentiation in neonatal rat cardiac fibroblasts
7. Vincristine and dexamethasone pulses in addition to maintenance therapy among pediatric acute lymphoblastic leukemia (GD‐ALL‐2008): An open‐label, multicentre, randomized, phase III clinical trial
8. Nucleophosmin mutations confer an independent favorable prognostic impact in 869 pediatric patients with acute myeloid leukemia
9. Chidamide as maintenance after chemotherapy or hematopoietic stem cell transplantation in 27 children with T-cell lymphoblastic leukemia: A real-world prospective study
10. Unconventional treatment for an unusual cauda equina syndrome associated with nontuberculous mycobacteria after allogenic stem cell transplantation in a child with acute lymphoblastic leukemia
11. Prognostic significance of CNSL at diagnosis of childhood B-cell acute lymphoblastic leukemia: A report from the South China Children’s Leukemia Group
12. Umbilical cord blood: A promising source for allogeneic CAR-T cells
13. Mutational landscape and clinical outcome of pediatric acute myeloid leukemia with 11q23/KMT2Arearrangements
14. Corticosteroid in Combination with Leflunomide and Mesenchymal Stem Cells for Treatment of Pediatric Idiopathic Pulmonary Hemosiderosis
15. Unconventional treatment for an unusual cauda equina syndrome associated with nontuberculous mycobacteria after allogenic stem cell transplantation in a child with acute lymphoblastic leukemia.
16. Comprehensive Analysis of Potential Biomarkers of Acute Lymphoblastic Leukemia in Children by Using a Competing Endogenous RNA Network
17. Optimal time-points for detecting expression levels of BAALC, EVI1, and WT1 genes in patients with acute myeloid leukemia: a meta-analysis
18. Mutational landscape and clinical outcome of pediatric acute myeloid leukemia with 11q23/KMT2A rearrangements.
19. Prognostic Value and Outcome for ETV6/RUNX1-Positive Pediatric Acute Lymphoblastic Leukemia: A Report From the South China Children’s Leukemia Group
20. Therapeutic efficacy of focal adhesion kinase downregulation in REH cells by RNA interference
21. HMGB1 translocation is involved in the transformation of autophagy complexes and promotes chemoresistance in leukaemia
22. Wilms Tumor 1 Mutations Are Independent Poor Prognostic Factors in Pediatric Acute Myeloid Leukemia
23. Efficacy of thalidomide treatment in children with transfusion dependent β-thalassemia: a retrospective clinical study
24. Efficacy and safety of eltrombopag in the treatment of Chinese children with chronic immune thrombocytopenia
25. Eltrombopag as first‐line treatment for thrombocytopenia among paediatric patients after allogeneic haematopoietic stem cell transplantation
26. Wilms Tumor 1 Mutations are Independent Poor Prognostic Factors in Pediatric Acute Myeloid Leukemia
27. Efficacy and safety of eltrombopag in the treatment of Chinese children with chronic immune thrombocytopenia.
28. Application of Mesenchymal Stromal Cells in Bone Marrow Transplantation for Sensitized Recipients
29. Hyperleukocytosis predicts inferior clinical outcome in pediatric acute myeloid leukemia
30. Hematopoietic stem cell transplantation for children with thalassemia major in china
31. Eltrombopag as first‐line treatment for thrombocytopenia among paediatric patients after allogeneic haematopoietic stem cell transplantation.
32. Iron Metabolism and Oxidative Status in Patients with Hb H Disease
33. Severe hypertension is an independent risk factor for posterior reversible encephalopathy syndrome post-hematopoietic cell transplantation in children with thalassemia major
34. Nuclear Localization Leucine-Rich-Repeat Protein 1 Deficiency Protects Against Cardiac Hypertrophy by Pressure Overload
35. Synergism between the mTOR inhibitor rapamycin and FAK down-regulation in the treatment of acute lymphoblastic leukemia
36. Critical Role of Sensitized Serum in Rejection of Allogeneic Bone Marrow Cells
37. 20(S)-Ginsenoside Rh2 Induces Apoptosis in Human Leukaemia Reh Cells through Mitochondrial Signaling Pathways
38. The Current Status of β-Thalassemia Major in Mainland China
39. Pure red cell aplasia associated with cytomegalovirus and Epstein–Barr virus infection in seven cases of Chinese children
40. Homing and engraftment of bone marrow cells derived from different donors in a murine model of sensitization
41. Albendazole Therapy for Coagulation Abnormality in Children with Eosinophilia
42. Autoimmune Hemolytic Anemia in Patients with β-Thalassemia Major
43. Evaluation of Hepatic Iron Overload in Chinese Children With β-Thalassemia Major
44. WITHDRAWN: Therapeutic efficacy of focal adhesion kinase downregulation in REH cells by RNA interference
45. PANEL REACTIVE ANTIBODY IN THALASSEMIC SERUM INHIBITS PROLIFERATION AND DIFFERENTIATION OF CORD BLOOD CD34+CELLS IN VITRO
46. Influence of Blocking B7/CD28 and CD40/CD154 Co-stimulatory Signals on Immune Function of Sensitized Mice.
47. Effects of CD4+ CD25+ Regulatory T Cells on Allogeneic Hematopoietic Stem Cell Transplantation in Sensitized Mice.
48. PANEL REACTIVE ANTIBODY IN THALASSEMIC SERUM INHIBITS PROLIFERATION AND DIFFERENTIATION OF CORD BLOOD CD34+ CELLS IN VITRO.
49. Severe hypertension is an independent risk factor for posterior reversible encephalopathy syndrome post‐hematopoietic cell transplantation in children with thalassemia major.
50. [Expression Changes of Hepcidin and Ferroportin 1 in Murine Model of Iron Overload].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.